Protocol summary

Summary
Objective: To determine the effect of valerian on cognitive disorders in hemodialysis' patients. Inclusion criteria: Over 18 years of age; hemodialysis 3 times a week for 3 hours; for more than 3 months; full consciousness; hearing and speech ability; and not having sensitivity to plants. Exclusion criteria: Physical or mental disability; drug abuse; cancer; hearing or visual disorder; experienced recent stressful event; kidney transplant; acute illness; body mass index over 30; liver disease; hepatitis; cirrhosis; travel; or death of the patient.Population under Study: Hemodialysis' patients of Kowsar in Semnan, 15 Khordad in Mahdishahr and Emam in Garmsar hospitals. Sample size: A pilot study including 30 patients, would determine the size of samples. First intervention: Group A use Valerian capsules (Sedamin 530 mg, Goldaru Co.) 60 minutes before bedtime for one month. After one month cleaning, group A will receive placebo. Completion of MMSE questionnaires and EEG (day after hemodialysis) is done before and after each intervention. Second intervention: Group B uses placebo capsules (starch 50 mg, Goldaru Co.) 60 minutes before bedtime for one month. After one month cleaning, group B will receive Valerian capsules (Sedamin 530 mg, Goldaru Co.). Completion of MMSE questionnaires and EEG (day after hemodialysis) is done before and after each intervention.

General information

Acronym
IRCT registration information
IRCT registration number: IRCT201606076318N7
Registration date: 2016-06-17, 1395/03/28
Registration timing: registered_while_recruiting

Last update:
Update count: 0
Registration date
2016-06-17, 1395/03/28
Registrant information
Name
Monir Nobahar
Name of organization / entity
Semnan University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 23 3365 4190
Email address
nobahar43@sem-ums.ac.ir
Recruitment status
Recruitment complete
Funding source
Semnan University of Medical Sciences
Expected recruitment start date
2016-05-26, 1395/03/06
Expected recruitment end date
2016-10-27, 1395/08/06
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The effect of valerian on cognitive disorders in hemodialysis' patients
Public title
The effect of valerian on cognitive disorders in hemodialysis' patients
Purpose
Supportive
Inclusion/Exclusion criteria
Inclusion criteria: Over 18 years of age; hemodialysis 3 times a week for 3 hours; for more than 3 months; full consciousness; hearing and speech ability; and not having sensitivity to plants. Exclusion criteria: Physical or mental disability; drug abuse; cancer; hearing or visual disorder; experienced recent stressful event; kidney transplant; acute illness; body mass index over 30; liver disease; hepatitis; cirrhosis; travel; or death of the patient.
Age
No age limit
Gender
Both
Phase
N/A
Groups that have been masked
None
Sample size
Target sample size: 30
Randomization (investigator's opinion)
Randomized
Randomization description
Blinding (investigator's opinion)
Double blinded
Blinding description
Placebo
Used
Assignment
Crossover
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Semnan University of Medical Sciences
Street address
Nursing and Paramedical Faculty, University of Medical Sciences, Semnan
City
Semnan
Country
Iran (Islamic Republic of)
Postal code
Approval date
2016-05-25, 1395/03/05
Ethics committee reference number
IR.SEMUMS.REC.1395.25

Health conditions studied

1

Description of health condition studied
Hemodialysis patients
ICD-10 code
F02.8
ICD-10 code description
Dementia in other specified diseases classified elsewhere

Primary outcomes

1

Description
Cognitive status
Timepoint
Before the intervention, one month after the first intervention, one month after the cleansing and one month after the second intervention
Method of measurement
In this study, Cognitive status is measured by using Electroencephalography (EEG) and MMSE questionnaire. This measurement is performed within three consecutive months (before the intervention, one month after the first intervention, one month after the cleansing and one month after the second intervention). The score for total cognitive health is (25-30), for mild cognitive disorder is (21-24), for moderate disorder is (10-20) and for severe disorder is (<9). Information for each person will be recorded in their personal questionnaire.

Secondary outcomes

empty

Intervention groups

1

Description
Group A uses Valerian capsules (Sedamin 530 mg, Goldaru Co.) 60 minutes before bedtime for one month. After one month (cleaning or wash out), the type of treatment between two groups is replaced, group A will receive placebo. Completion of Mini Mental State Examination (MMSE) questionnaires and EEG (day after hemodialysis) is done before and after each intervention.
Category
N/A

2

Description
Group B uses placebo capsules (starch 50 mg, Goldaru Co.) 60 minutes before bedtime for one month. After one month (cleaning or wash out), the type of treatment between two groups is replaced, group B will receive Valerian capsules (Sedamin 530 mg, Goldaru Co.). Completion of Mini Mental State Examination (MMSE) questionnaires and EEG (day after hemodialysis) is done before and after each intervention.
Category
N/A

Recruitment centers

1

Recruitment center
Name of recruitment center
Kowsar in Semnan, Khordad The 15th in Mahdishahr and Emam in Garmsar
Full name of responsible person
Monir Nobahar
Street address
Faculty Nursing and Paramedical, Semnan University of Medical Sciences, Semnan
City
Semnan
Country
Iran (Islamic Republic of)

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Semnan University of Medical Sciences
Full name of responsible person
Dr. Ali Rashidypour
Street address
Faculty Nursing and Paramedical, Semnan University of Medical Sciences, Semnan
City
Semnan
Country
Iran (Islamic Republic of)
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Semnan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
empty
Domestic or foreign origin
empty
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
empty

Person responsible for general inquiries

Contact
Name of organization / entity
Semnan University of Medical Sciences
Full name of responsible person
Monir Nobahar
Position
Associate Professor of Semnan University of Medical Sciences
Other areas of specialty/work
Street address
Faculty Nursing and Paramedical, Semnan University of Medical Sciences, Semnan
City
Semnan
Country
Iran (Islamic Republic of)
Postal code
Phone
+98 23 3365 4170
Fax
Email
nobahar43@semums.ac.ir; Nobahar43@yahoo.com
Web page address

Person responsible for scientific inquiries

Contact
Name of organization / entity
Semnan University of Medical Sciences
Full name of responsible person
Monir Nobahar
Position
PhD Nursing
Other areas of specialty/work
Street address
Faculty Nursing and Paramedical, Semnan University of Medical Sciences, Semnan
City
Semnan
Country
Iran (Islamic Republic of)
Postal code
Phone
+98 23 3365 4170
Fax
Email
Nobahar43@semums.ac.ir; Nobahar43@yahoo.com
Web page address

Person responsible for updating data

Contact
Name of organization / entity
Semnan University of Medical Sciences
Full name of responsible person
Monir Nobahar
Position
Associate Professor
Other areas of specialty/work
Street address
Faculty Nursing and Paramedical, Semnan University of Medical Sciences, Semnan
City
Semnan
Country
Iran (Islamic Republic of)
Postal code
Phone
+98 23 3365 4170
Fax
Email
Nobahar43@semums.ac.ir; Nobahar43@yahoo.com
Web page address

Sharing plan

Deidentified Individual Participant Data Set (IPD)
empty
Study Protocol
empty
Statistical Analysis Plan
empty
Informed Consent Form
empty
Clinical Study Report
empty
Analytic Code
empty
Data Dictionary
empty
Loading...